posted on 2023-08-21, 21:05authored byKornelia
J. Skowron, Chetana Baliga, Tatum Johnson, Kyle M. Kremiller, Alexandra Castroverde, Trevor T. Dean, A’Lester
C. Allen, Ana M. Lopez-Hernandez, Elena V. Aleksandrova, Dorota Klepacki, Alexander S. Mankin, Yury S. Polikanov, Terry W. Moore
With the growing crisis of antimicrobial resistance,
it is critical
to continue to seek out new sources of novel antibiotics. This need
has led to renewed interest in natural product antimicrobials, specifically
antimicrobial peptides. Nonlytic antimicrobial peptides are highly
promising due to their unique mechanisms of action. One such peptide
is apidaecin (Api), which inhibits translation termination through
stabilization of the quaternary complex of the ribosome-apidaecin-tRNA-release
factor. Synthetic derivatives of apidaecin have been developed, but
structure-guided modifications have yet to be considered. In this
work, we have focused on modifying key residues in the Api sequence
that are responsible for the interactions that stabilize the quaternary
complex. We present one of the first examples of a highly modified
Api peptide that maintains its antimicrobial activity and interaction
with the translation complex. These findings establish a starting
point for further structure-guided optimization of Api peptides.